Fri, 06 Jul 2018 11:35:14 GMT
ObsEva views Swiss IPO, trading debut this month
ObsEva, the Swiss drug development firm, is planning a listing on the Zurich SIX Swiss Exchange and a trading debut scheduled for July 13, as it seeks expansion among EU investors.